---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-096807"
form_type: "8-K"
ticker: "SMNR"
cik: "0001913577"
company_name: "Semnur Pharmaceuticals, Inc."
filed_at: "2024-11-12T23:59:59+00:00"
generated_at: "2026-05-30T02:18:53.337773+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Denali Capital extends business combination deadline to Dec 11, 2024 with $15,064 deposit

## Summary
- Deposited $15,063.74 into trust account to extend deadline from Nov 11 to Dec 11, 2024.
- Funding came from a convertible promissory note issued to Scilex Holding (SCLX) for up to $180,000.
- Note bears no interest, repayable upon business combination or liquidation; convertible at $10.00/share.
- Remaining $119,772.04 under the note may fund future monthly extensions.
- SPAC (DECA) is a blank-check company seeking a business combination.

## SEC filing metadata
- accession: 0001213900-24-096807
- form_type: 8-K
- ticker: SMNR
- cik: 0001913577
- company_name: Semnur Pharmaceuticals, Inc.
- filed_at: 2024-11-12T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1913577/000121390024096807/0001213900-24-096807-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1913577/000121390024096807/ea0220633-8k425_denali.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-096807
- JSON: https://secwatch.observer/filing/0001213900-24-096807.json
- Plain text: https://secwatch.observer/filing/0001213900-24-096807.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.